Sitemap > Breaking Research > Immunology & Inflammatory Diseases
Displaying 1351 - 1400 of 5698 results
- Loss of PECAM-1 function impairs alveolarization.
- Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase.
- Developments in the apheresis procedure for the treatment of inflammatory bowel disease.
- Preliminary data on the use of apheresis in inflammatory bowel disease.
- Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center.
- Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.
- Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates.
- 4-Aminophenoxyacetic acids as a novel class of reversible cathepsin K inhibitors.
- 5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethers.
- Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor.
- Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
- Natural killer T-cells participate in rejection of islet allografts in the liver of mice.
- Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.
- Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
- Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.
- Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes.
- Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.
- Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation?
- Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose.
- CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16.
- C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways.
- Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage.
- Absence of CC chemokine receptor 8 enhances innate immunity during septic peritonitis.
- Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.
- The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study.
- Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
- The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
- Toll-like receptor 9 signaling protects against murine lupus.
- Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
- Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
- Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors.
- Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice.
- Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
- Blockade of both CD28/B7 and OX40/OX40L co-stimulatory signal pathways prolongs the survival of islet xenografts.
- Effect of FTY720 in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1.
- Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation.
- Transfection of CD40Ig into liver prevents acute rejection in rat liver transplantation.
- The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.
- Absence of T-regulatory cell expression and function in atopic dermatitis skin.
- Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.
- A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis.
- The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease.
- Treatment of intractable painful diabetic neuropathy with intravenous lignocaine.
- Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis.
- Elimination of innate immune responses and liver inflammation by PEGylation of adenoviral vectors and methylprednisolone.
- Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
- Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children.
- Characterisation of CD8 monoclonal antibody-induced protection from diabetes in NOD mice.
- Edaravone inhibits rheumatoid synovial cell proliferation and migration.
- Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 Next >